Breath octane and acetaldehyde as markers for acute respiratory distress syndrome in invasively ventilated patients suspected to have ventilator-associated pneumonia

Rationale The concentration of octane and acetaldehyde in exhaled breath has good diagnostic accuracy for acute respiratory distress syndrome (ARDS). We aimed to determine whether breath octane and acetaldehyde are able to distinguish the presence and absence of ARDS in critically ill patients suspected to have ventilator-associated pneumonia (VAP). Methods This is a secondary analysis of a prospective observational study into exhaled breath analysis using gas chromatography–time-of-flight mass spectrometry. Difference in the relative abundance of octane and acetaldehyde in exhaled breath was compared between patients with and without ARDS using the Mann–Whitney U-test and the association was quantified using logistic regression. The discriminative accuracy of octane and acetaldehyde, alone or in combination, was calculated using the area under the receiver operating characteristic curve (AUROCC). Results We included 98 patients, of whom 32 had ARDS and 66 did not. The area under the acetaldehyde peak was higher in patients with ARDS (p=0.03), and associated with the presence of ARDS (OR 1.06 per 100 000 count change, 95% CI 1.02–1.13 per 100 000 count change; p=0.01). A combined model with octane and acetaldehyde showed a high specificity and low sensitivity (90% and 40.6%, respectively), with a low accuracy (AUROCC 0.65, 95% CI 0.53–0.78). Conclusion Patients suspected to have VAP with ARDS had a higher acetaldehyde concentration in exhaled breath than patients suspected to have VAP without ARDS. However, in this patient population, discrimination of these breath biomarkers for ARDS was poor, indicating the difficulty of translating diagnostic tests between clinical settings. Octane and acetaldehyde had poor discriminative accuracy for ARDS in a population suspected to have VAP. Future research should take into account the potential overlap in exhaled breath signal between patients with ARDS and competing diseases such as VAP. https://bit.ly/3KOrq7H

[1]  D. Sessler,et al.  Volutrauma Increases Exhaled Pentanal in Rats: A Potential Breath Biomarker for Ventilator-Induced Lung Injury , 2021, Anesthesia and analgesia.

[2]  A. Torres,et al.  Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? , 2020, European Respiratory Review.

[3]  K. Van Steen,et al.  Exhaled Volatile Organic Compounds are Able to Discriminate between Neutrophilic and Eosinophilic Asthma. , 2019, American journal of respiratory and critical care medicine.

[4]  R. Hyzy,et al.  Rapid breath analysis for acute respiratory distress syndrome diagnostics using a portable two-dimensional gas chromatography device , 2019, Analytical and Bioanalytical Chemistry.

[5]  P. Póvoa,et al.  Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome , 2018, Journal of intensive care medicine.

[6]  Hans Weda,et al.  Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients , 2017, International journal of molecular sciences.

[7]  T. van der Poll,et al.  Comparative Analysis of the Host Response to Community-acquired and Hospital-acquired Pneumonia in Critically Ill Patients. , 2016, American journal of respiratory and critical care medicine.

[8]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[9]  Rianne Fijten,et al.  Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia , 2015, Scientific Reports.

[10]  A. Smolinska,et al.  Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia. , 2015, Respiratory medicine.

[11]  Cheng-Ta Yang,et al.  Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy , 2015, Critical Care.

[12]  Hans Weda,et al.  Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome , 2014, European Respiratory Journal.

[13]  A Smolinska,et al.  Current breathomics—a review on data pre-processing techniques and machine learning in metabolomics breath analysis , 2014, Journal of breath research.

[14]  P. Zimmerman,et al.  Exhaled breath analysis for lung cancer. , 2013, Journal of thoracic disease.

[15]  Peter J. Sterk,et al.  Volatile Metabolites of Pathogens: A Systematic Review , 2013, PLoS pathogens.

[16]  Ó. Peñuelas,et al.  Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. , 2013, American journal of respiratory and critical care medicine.

[17]  Richard Beale,et al.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material , 2012, Intensive Care Medicine.

[18]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[19]  F. V. van Schooten,et al.  The versatile use of exhaled volatile organic compounds in human health and disease , 2012, Journal of breath research.

[20]  J W Dallinga,et al.  A profile of volatile organic compounds in breath discriminates COPD patients from controls. , 2009, Respiratory medicine.

[21]  Simone Meinardi,et al.  Journal of Translational Medicine BioMed Central Methodology , 2005 .

[22]  S. Zakhari.  Overview: How Is Alcohol Metabolized by the Body? , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[23]  P Gastmeier,et al.  [Guidelines for preventing health-care-associated pneumonia]. , 2005, Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS.

[24]  L. Ng,et al.  Advanced Glycation End Products Stimulate an Enhanced Neutrophil Respiratory Burst Mediated Through the Activation of Cytosolic Phospholipase A2 and Generation of Arachidonic Acid , 2003, Circulation.

[25]  M. Drent,et al.  Bronchoalveolar lavage fluid differential cell count. How many cells should be counted? , 2002, Analytical and quantitative cytology and histology.

[26]  P. Parsons,et al.  An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. , 1996, Critical care medicine.

[27]  T. Evans,et al.  Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. , 1996, Critical care medicine.

[28]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[29]  A. Van Gossum,et al.  Breath alkanes as an index of lipid peroxidation. , 1989, European Respiratory Journal.

[30]  D A Rasley,et al.  Surveillance of nosocomial infections , 1989, Critical care nursing quarterly.

[31]  R. Baughman,et al.  Changes in fatty acids in phospholipids of the bronchoalveolar fluid in bacterial pneumonia and in adult respiratory distress syndrome. , 1984, Clinical chemistry.

[32]  B. Babior,et al.  The O2(-) -forming oxidase responsible for the respiratory burst in human neutrophils. Properties of the solubilized enzyme. , 1979, The Journal of biological chemistry.

[33]  P. Sterk,et al.  Breathomics in lung disease. , 2015, Chest.

[34]  C. Bridges,et al.  Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.